Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biased G Protein-Independent Signaling of Dopamine D1-D3 Receptor Heteromers in the Nucleus Accumbens
Xavier Guitart, Estefanía Moreno, William Rea, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 10, pp. 6756-6769
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia
Jean Claude Martel, Silvia Gatti McArthur
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 190
Immunomodulatory Effects of Dopamine in Inflammatory Diseases
Yifei Feng, Yan Lü
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 71
Control of glutamate release by complexes of adenosine and cannabinoid receptors
Attila Köfalvi, Estefanía Moreno, Arnau Cordomí, et al.
BMC Biology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 68
Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders
Béla Kiss, I. Laszlovszky, Balázs Krámos, et al.
Biomolecules (2021) Vol. 11, Iss. 1, pp. 104-104
Open Access | Times Cited: 51
G protein-coupled receptor-effector macromolecular membrane assemblies (GEMMAs)
Sergi Ferré, Francisco Ciruela, Carmen Dessauer, et al.
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107977-107977
Open Access | Times Cited: 49
Membrane Estrogen Receptor (GPER) and Follicle-Stimulating Hormone Receptor (FSHR) Heteromeric Complexes Promote Human Ovarian Follicle Survival
Livio Casarini, Clara Lazzaretti, Elia Paradiso, et al.
iScience (2020) Vol. 23, Iss. 12, pp. 101812-101812
Open Access | Times Cited: 41
Dopamine D3 Receptor Heteromerization: Implications for Neuroplasticity and Neuroprotection
Federica Bono, Veronica Mutti, Chiara Fiorentini, et al.
Biomolecules (2020) Vol. 10, Iss. 7, pp. 1016-1016
Open Access | Times Cited: 39
Cell-Type-Specific Adaptions in Striatal Medium-Sized Spiny Neurons and Their Roles in Behavioral Responses to Drugs of Abuse
Marie‐Charlotte Allichon, Vanesa Ortiz, Paula A. Pousinha, et al.
Frontiers in Synaptic Neuroscience (2021) Vol. 13
Open Access | Times Cited: 27
Oligomerization of G protein-coupled receptors: Still doubted?
Sergi Ferré, Francisco Ciruela, Vicent Casadó, et al.
Progress in molecular biology and translational science (2019), pp. 297-321
Open Access | Times Cited: 31
Functional and Neuroprotective Role of Striatal Adenosine A2AReceptor Heterotetramers
Sergi Ferré, Francisco Ciruela
Journal of Caffeine and Adenosine Research (2019) Vol. 9, Iss. 3, pp. 89-97
Open Access | Times Cited: 30
Unveiling the Differences in Signaling and Regulatory Mechanisms between Dopamine D2 and D3 Receptors and Their Impact on Behavioral Sensitization
Kyeong‐Man Kim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6742-6742
Open Access | Times Cited: 10
Heteromerization of dopaminergic receptors in the brain: Pharmacological implications
Desye Misganaw
Pharmacological Research (2021) Vol. 170, pp. 105600-105600
Closed Access | Times Cited: 21
The World of GPCR dimers – Mapping dopamine receptor D2 homodimers in different activation states and configuration arrangements
Beatriz Bueschbell, Pedro R. Magalhães, Carlos A.V. Barreto, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 4336-4353
Open Access | Times Cited: 7
Pharmacological evidence for transactivation within melatonin MT 2 and serotonin 5‐HT 2C receptor heteromers in mouse brain
Romain Gerbier, Delphine Ndiaye‐Lobry, Pablo B. Martínez de Morentin, et al.
The FASEB Journal (2020) Vol. 35, Iss. 1
Closed Access | Times Cited: 20
The transmembrane domains of GPCR dimers as targets for drug development
Xin Cai, Dexiu Wang, Rumin Zhang, et al.
Drug Discovery Today (2022) Vol. 28, Iss. 1, pp. 103419-103419
Closed Access | Times Cited: 12
Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease
Abdeslam Chagraoui, Giuseppe Di Giovanni, Philippe De Deurwaerdère
Biomolecules (2022) Vol. 12, Iss. 2, pp. 243-243
Open Access | Times Cited: 11
Akathisia and Restless Legs Syndrome
Sergi Ferré, Xavier Guitart, César Quiroz, et al.
Sleep Medicine Clinics (2021) Vol. 16, Iss. 2, pp. 249-267
Closed Access | Times Cited: 15
Class A and C GPCR Dimers in Neurodegenerative Diseases
Irina S. Moreira, Ana B. Caniceiro, Beatriz Bueschbell, et al.
Current Neuropharmacology (2022) Vol. 20, Iss. 11, pp. 2081-2141
Open Access | Times Cited: 10
Pharmacological targeting of G protein-coupled receptor heteromers
Estefanía Moreno, Nil Casajuana‐Martin, Michael Coyle, et al.
Pharmacological Research (2022) Vol. 185, pp. 106476-106476
Open Access | Times Cited: 10
Exploring functional consequences of GPCR oligomerization requires a different lens
Kyla Bourque, Jace Jones-Tabah, Dominic Devost, et al.
Progress in molecular biology and translational science (2019), pp. 181-211
Closed Access | Times Cited: 14
Exception That Proves the Rule: Investigation of Privileged Stereochemistry in Designing Dopamine D3R Bitopic Agonists
Francisco O. Battiti, Amy Hauck Newman, Alessandro Bonifazi
ACS Medicinal Chemistry Letters (2020) Vol. 11, Iss. 10, pp. 1956-1964
Open Access | Times Cited: 11
Dopamine D3 Receptor Plasticity in Parkinson’s Disease and L-DOPA-Induced Dyskinesia
Kathryn Lanza, Christopher Bishop
Biomedicines (2021) Vol. 9, Iss. 3, pp. 314-314
Open Access | Times Cited: 10
Targeting the receptor-based interactome of the dopamine D1 receptor: looking for heteromer-selective drugs
Verònica Casadó-Anguera, Antoni Cortés, Vicent Casadó, et al.
Expert Opinion on Drug Discovery (2019) Vol. 14, Iss. 12, pp. 1297-1312
Closed Access | Times Cited: 10
Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat
Kathryn Lanza, Katherine Chemakin, Sarah Lefkowitz, et al.
Psychopharmacology (2019) Vol. 237, Iss. 1, pp. 155-165
Closed Access | Times Cited: 9
Heteromerization between α2A adrenoceptors and different polymorphic variants of the dopamine D4 receptor determines pharmacological and functional differences. Implications for impulsive-control disorders
Verònica Casadó-Anguera, Estefanía Moreno, Marta Sánchez‐Soto, et al.
Pharmacological Research (2021) Vol. 170, pp. 105745-105745
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top